Transforming global healthcare by advancing digital therapeutics to improve clinical and health economic outcomes.
Broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics with patients, clinicians, payors, policymakers through education, advocacy, and cross-industry collaboration.
Founded in 2017, the Digital Therapeutics Alliance is a 501(c)(6) non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. As the leading international organization on digital therapeutic thought leadership and education, the Digital Therapeutics Alliance provides patients, clinicians, payors, and policymakers with the necessary tools to evaluate and utilize DTx products.
DTA brings together leading organizations through worldwide collaboration to improve clinical and health economic outcomes by advancing the use of high quality, evidence-based digital therapeutics by patients, clinicians, payors, and policymakers.
Learn more about DTA’s current initiatives and milestones.
Advancing DTx
